Neurogenic Bladder: Recurrent Urinary Tract Infections—Beyond Antibiotics

Alison C. Castle, Albert Park, Alissa J. Mitchell, Donna Z. Bliss, Jeffrey A. Gelfand, Elise J.B. De

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Purpose of Review: Our goal was to identify evidenced-based strategies to prevent and treat patients with neurogenic bladder who suffer from recurrent urinary tract infections. We focused on therapy beyond standard antibiotics to address a multitude of factors implicated in these complex infections. Recent Findings: Anatomic and functional components specific to neurogenic bladder contribute to the risk of infection and require close clinical monitoring. The host-pathogen interaction is one that allows for colonization of bacteria in the bladder. We recognize that bacteriuria in the neurogenic bladder population does not equate with infection. Local antibiotic treatment and oral supplements are often not adequate to eliminate infection nor prevent recurrent infection due to biofilms. However, novel medical therapies, such as photodynamic therapy, bacterial interference, and infrared laser therapy to augment local immune cells, are promising options to prevent and treat symptomatic infection. Summary: A combination approach including management of anatomic and functional factors with medical intervention can significantly improve frequency of urinary infection. Further study of non-antibiotic therapeutic strategies is much needed as we recognize the complexity of the urinary biomes and the limitations of antibiotic therapies.

Original languageEnglish (US)
Pages (from-to)191-200
Number of pages10
JournalCurrent Bladder Dysfunction Reports
Issue number4
StatePublished - Dec 1 2018


  • Catheter-associated UTI
  • Neurogenic UTI
  • Neurogenic bladder
  • Recurrent urinary tract infection


Dive into the research topics of 'Neurogenic Bladder: Recurrent Urinary Tract Infections—Beyond Antibiotics'. Together they form a unique fingerprint.

Cite this